5 tips to reduce the liability risk of prescribing GLP-1s

As a specialized medical malpractice broker, I am focused on protecting my physician and surgeon clients from the imminent surge of weight loss drug-related malpractice claims. In this article, we give five tips for physicians to protect themselves from claims related to glucagon-like peptide-1 (GLP-1) medications like Ozempic.

Max Schloemann is the founder of MEDPLI Professional Liability Insurance